Non-receipt of guideline-concordant treatment in pancreatic cancer is linked to worse outcomes and distinct patient patterns.

• 32.4% of patients in a study cohort did not receive guideline-concordant treatment.
• Key factors include socioeconomic status, access to care, and patient vulnerability at first contact.

Addressing these factors may improve treatment access and outcomes.

• Areas with higher deprivation indices showed increased non-receipt, especially in emergency department patients.